tiprankstipranks
Trending News
More News >
Chemed (CHE)
:CHE
US Market
Advertisement

Chemed (CHE) Stock Forecast & Price Target

Compare
334 Followers
See the Price Targets and Ratings of:

CHE Analyst Ratings

Strong Buy
4Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Chemed
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CHE Stock 12 Month Forecast

Average Price Target

$579.75
▲(40.61%Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Chemed in the last 3 months. The average price target is $579.75 with a high forecast of $650.00 and a low forecast of $500.00. The average price target represents a 40.61% change from the last price of $412.30.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"416":"$416","651":"$651","474.75":"$474.8","533.5":"$533.5","592.25":"$592.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":650,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$650.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":579.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$579.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":500,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$500.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[416,474.75,533.5,592.25,651],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,417.85,435.70769230769235,453.56538461538463,471.42307692307696,489.28076923076924,507.13846153846157,524.9961538461539,542.8538461538462,560.7115384615385,578.5692307692308,596.4269230769231,614.2846153846153,632.1423076923077,{"y":650,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,417.85,430.30384615384617,442.7576923076923,455.21153846153845,467.66538461538465,480.1192307692308,492.57307692307694,505.0269230769231,517.4807692307693,529.9346153846154,542.3884615384616,554.8423076923077,567.2961538461539,{"y":579.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,417.85,424.1692307692308,430.48846153846154,436.8076923076923,443.1269230769231,449.44615384615383,455.7653846153846,462.0846153846154,468.4038461538462,474.7230769230769,481.0423076923077,487.36153846153843,493.6807692307692,{"y":500,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":563.68,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":537.63,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":584.6,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":591.2,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":530.25,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":528.85,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":561,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":600.28,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":618.02,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":573.24,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":570.39,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":483.92,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":417.85,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$650.00Average Price Target$579.75Lowest Price Target$500.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CHE
TipRanks AITipRanks
Not Ranked
TipRanks
$437
Hold
5.99%
Upside
Reiterated
08/01/25
Chemed's overall stock score of 62 reflects strong financial performance, tempered by negative technical indicators and a conservative valuation. The recent earnings call and corporate event of reduced guidance introduce additional uncertainty. The company's robust financial health supports its resilience against these challenges, yet the bearish technical outlook and market reactions to revised guidance weigh on sentiment.
Oppenheimer
$650$580
Buy
40.67%
Upside
Reiterated
07/31/25
Chemed price target lowered to $580 from $650 at OppenheimerChemed price target lowered to $580 from $650 at Oppenheimer
RBC Capital Analyst forecast on CHE
Ben HendrixRBC Capital
RBC Capital
$640$589
Buy
42.86%
Upside
Reiterated
07/31/25
RBC Capital Keeps Their Buy Rating on Chemed (CHE)RBC Capital analyst Ben Hendrix lowered the price target on Chemed (NYSE: CHE) to $589.00 (from $640.00) while maintaining a Outperform rating.
Jefferies
$500
Hold
21.27%
Upside
Initiated
07/25/25
Chemed's Hold Rating: Navigating Short-Term Challenges Amid Strong Long-Term ProspectsWe initiate coverage on hospice and plumbing services provider CHE with a Hold/$500 PT. While we are big fans of CHE and the hospice space and give credit to mgmt for their track record of execution and capital allocation, the impact of recent issues related to the Medicare cap (particularly in FL) will likely carry over into '26 and limit the co's ability to achieve the Street's current '26 EBITDA growth (+12% vs our 8%) expectations, prompting our Hold. '26 Street EBITDA at Cap Issue. While we are positively-disposed on CHE's LT fundamentals, we initiate coverage with a Hold given our concern that Street ests. for '26 are too high.
Bank of America Securities Analyst forecast on CHE
Joanna GajukBank of America Securities
Bank of America Securities
$708$650
Buy
57.65%
Upside
Reiterated
06/30/25
Chemed's Resilience Amid Challenges: Justifying a Buy Rating with Strong Long-Term Prospects
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on CHE
TipRanks AITipRanks
Not Ranked
TipRanks
$437
Hold
5.99%
Upside
Reiterated
08/01/25
Chemed's overall stock score of 62 reflects strong financial performance, tempered by negative technical indicators and a conservative valuation. The recent earnings call and corporate event of reduced guidance introduce additional uncertainty. The company's robust financial health supports its resilience against these challenges, yet the bearish technical outlook and market reactions to revised guidance weigh on sentiment.
Oppenheimer
$650$580
Buy
40.67%
Upside
Reiterated
07/31/25
Chemed price target lowered to $580 from $650 at OppenheimerChemed price target lowered to $580 from $650 at Oppenheimer
RBC Capital Analyst forecast on CHE
Ben HendrixRBC Capital
RBC Capital
$640$589
Buy
42.86%
Upside
Reiterated
07/31/25
RBC Capital Keeps Their Buy Rating on Chemed (CHE)RBC Capital analyst Ben Hendrix lowered the price target on Chemed (NYSE: CHE) to $589.00 (from $640.00) while maintaining a Outperform rating.
Jefferies
$500
Hold
21.27%
Upside
Initiated
07/25/25
Chemed's Hold Rating: Navigating Short-Term Challenges Amid Strong Long-Term ProspectsWe initiate coverage on hospice and plumbing services provider CHE with a Hold/$500 PT. While we are big fans of CHE and the hospice space and give credit to mgmt for their track record of execution and capital allocation, the impact of recent issues related to the Medicare cap (particularly in FL) will likely carry over into '26 and limit the co's ability to achieve the Street's current '26 EBITDA growth (+12% vs our 8%) expectations, prompting our Hold. '26 Street EBITDA at Cap Issue. While we are positively-disposed on CHE's LT fundamentals, we initiate coverage with a Hold given our concern that Street ests. for '26 are too high.
Bank of America Securities Analyst forecast on CHE
Joanna GajukBank of America Securities
Bank of America Securities
$708$650
Buy
57.65%
Upside
Reiterated
06/30/25
Chemed's Resilience Amid Challenges: Justifying a Buy Rating with Strong Long-Term Prospects
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Chemed

1 Month
xxx
Success Rate
23/43 ratings generated profit
53%
Average Return
+0.19%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.49% of your transactions generating a profit, with an average return of +0.19% per trade.
3 Months
xxx
Success Rate
27/43 ratings generated profit
63%
Average Return
+3.13%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.79% of your transactions generating a profit, with an average return of +3.13% per trade.
1 Year
Success Rate
31/43 ratings generated profit
72%
Average Return
+12.60%
reiterated a buy rating 3 days ago
Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 72.09% of your transactions generating a profit, with an average return of +12.60% per trade.
2 Years
xxx
Success Rate
28/43 ratings generated profit
65%
Average Return
+23.24%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 65.12% of your transactions generating a profit, with an average return of +23.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CHE Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
5
7
10
10
7
Hold
0
0
0
6
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
7
10
16
14
In the current month, CHE has received 7 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. CHE average Analyst price target in the past 3 months is 579.75.
Each month's total comprises the sum of three months' worth of ratings.

CHE Financial Forecast

CHE Earnings Forecast

Next quarter’s earnings estimate for CHE is $5.36 with a range of $5.23 to $5.42. The previous quarter’s EPS was $4.27. CHE beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 49.18% of the time in the same period. In the last calendar year CHE has Outperformed its overall industry.
Next quarter’s earnings estimate for CHE is $5.36 with a range of $5.23 to $5.42. The previous quarter’s EPS was $4.27. CHE beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 49.18% of the time in the same period. In the last calendar year CHE has Outperformed its overall industry.

CHE Sales Forecast

Next quarter’s sales forecast for CHE is $625.02M with a range of $621.95M to $627.91M. The previous quarter’s sales results were $618.80M. CHE beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 54.41% of the time in the same period. In the last calendar year CHE has Outperformed its overall industry.
Next quarter’s sales forecast for CHE is $625.02M with a range of $621.95M to $627.91M. The previous quarter’s sales results were $618.80M. CHE beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 54.41% of the time in the same period. In the last calendar year CHE has Outperformed its overall industry.

CHE Stock Forecast FAQ

What is CHE’s average 12-month price target, according to analysts?
Based on analyst ratings, Chemed’s 12-month average price target is 579.75.
    What is CHE’s upside potential, based on the analysts’ average price target?
    Chemed has 40.61% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CHE a Buy, Sell or Hold?
          Chemed has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Chemed’s price target?
            The average price target for Chemed is 579.75. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $650.00 ,the lowest forecast is $500.00. The average price target represents 40.61% Increase from the current price of $412.3.
              What do analysts say about Chemed?
              Chemed’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of CHE?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis